Close Menu

Ready or Not

At his blog, Neuroskeptic says broad-scale commercial fetal genome testing is "likely to become possible in the next few years." While researchers have already scanned fetal genomes to detect chromosomal abnormalities like Down syndrome, "those diseases are just the low-hanging fruit at the tip of the iceberg," Neuroskeptic says.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Nature survey finds a high level of support among scientists for former Vice President Joe Biden in the upcoming US election.

Two coronavirus vaccine trials that had been paused in the US have resumed.

The Scientist reports the physician behind Surgisphere inactivated his medical license in one state and received one in another.

In PLOS this week: analysis of link between somatic copy number and telomere length, sequencing study of individuals with gallbladder S. Typhi colonization, and more.